2025, Number 1
Next >>
Otorrinolaringología 2025; 70 (1)
Intratympanic steroid as initial management of sudden sensorineural hearing loss in chronic kidney disease on hemodialysis
Guevara PE, del Ángel LMC, Gutiérrez PJF, Solórzano FAS
Language: Spanish
References: 10
Page: 1-7
PDF size: 143.21 Kb.
ABSTRACT
Objective: To describe clinical evolution in patients with chronic kidney disease on treatment with hemodialysis
who develop sudden neurosensorial hearing loss posterior to the administration of four week doses of
intratympanic steroid, based on Siegel and Cheng criteria.
Materials and Methods: An observational, cohort, longitudinal, retrospective study was done in patients
with chronic kidney disease treated with hemodialysis and diagnosis of sudden hearing loss, from January 1st,
2022 to January 31st, 2023. Tonal audiometry was used for staging the patients based on the severity of hearing
loss. A second tonal audiometry was performed after treatment ended. Based on Siegel and Cheng’s criteria, it
was observed if improvement occurred, and the grade.
Results: Thirty-two patients were included. It was observed a recovery of hearing function in all patients of
the studied population, the gain was variable, and there were not infectious complications during the treatment
administration.
Conclusions: Intratympanic steroid is an effective treatment modality for patients who develop neurosensorial
sudden hearing loss in chronic kidney disease in treatment with hemodialysis. However, it is necessary to
make another study with a bigger population to improve the evidence level.
REFERENCES
Argaiz Eduardo R, Morales-Juárez L, Razo C, Ong L, Rafferty Q, et al . La carga de enfermedad renal crónicaen México. Análisis de datos basado en el estudio Global Burden of Disease 2021. Gac Méd Méx 2023; 159(6): 501-508. https://doi.org/10.24875/gmm.23000393
Amarillo EN, Hernando M, Eisenberg G, Granda M, et. al. Eficacia del corticoide intratimpánico comotratamiento de rescate en sordera súbita neurosensorial idiopática. Acta Otorrinol Esp 2019; 70 (4): 207-214.https://doi.org/10.1016/j.otorri.2018.04.009
Agrawal M, Singh CV. Sensorineural hearing loss in patients with chronic kidney disease: A comprehensivereview. Cureus 2023; 15 (11): e48244. https://doi.org/10.7759/cureus.48244
Gabr TA, Kotait MA, Okda HI. Audiovestibular functions in chronic kidney disease in relation to haemodialysis.J Laryngol Otol 2019; 133 (7): 592-599. https://doi.org/10.1017/S002221511900145
Meena RS, Aseri Y, Singh BK, Verma PC. Hearing loss in patients of chronic renal failure: a study of 100cases. Indian J Otolaryngol Head Neck Surg. 2012; 64 (4): 356-9. https://doi.org/10.1007/s12070-011-0405-5
Shim YJ, Choi HG, Wee JH. Association between chronic kidney disease and sudden sensorineural hearingloss: A Longitudinal follow-up studies using icd-10 codes in a national health screening cohort. J Clin Med2023; 12 (8): 2861. https://doi.org/10.3390/jcm12082861
Kang SM, Lim HW, Yu H. Idiopathic sudden sensorineural hearing loss in dialysis patients. Ren Fail 2018;40 (1): 170-174. https://doi.org/10.1080/0886022X.2018.1450760
Mudhol RS, Jahnavi. Hearing evaluation in patients with chronic renal failure: A 1 year cross-sectionalstudy in a tertiary care centre. Indian J Otolaryngol Head Neck Surg 2019; 71 (Suppl 2): 1633-1638. https://doi.org/10.1007/s12070-019-01701
Kumar KA, Hishamudin AD, Krishnan DA, Lingam H, et al. The effect of hemodialysis on hearing in chronickidney disease patients – A systematic review. Indian J Med Sci 2022; 74: 32-9. https://doi.org/10.25259/IJMS_135_2021
Cheng YF, Chu YC, Tu TY, Shiao AS, et al. Modified Siegel’s criteria for sudden sensorineural hearing loss:Reporting recovery outcomes with matched pretreatment hearing grades. J Chin Med Assoc 2018; 81 (11):1008-12. https://doi.org/10.1016/j.jcma.2018.03.012
Full text